Resolve is currently enrolling long covid patients into its phase 2 clinical trial with RSLV-132. Eligible patients will have been diagnosed with covid by PCR test at lease 6 months previous to enrollment and suffer from severe fatigue. The study is being conducted at three clinical sites:
Seattle, WA
Knoxville, TN
Pompano Beach, FL
For more information on the study please contact: [email protected]
ClinicalTrials.gov Identifier: NCT04944121